2021
DOI: 10.1101/2021.05.10.21256978
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Simple Mathematical Tool to Help Distribute Doses of ‘Two-Dose’ Covid-19 Vaccines among Non-Immunized and Partly-Immunized Population

Abstract: Background: Full immunization with two doses of Covid vaccine has been found to be a critical factor in preventing morbidity and mortality from the Covid-19 infection. However, due to the shortage of vaccines, a significant portion of the population is not getting vaccination in many countries. Also, the distribution of vaccine doses between prospective first dose recipient and second dose recipient is not uniformly planned, as seen in India's various states and union territories. It is recommended to give sec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…However, studies regarding the efficacy of Vero Cell vaccines are still ongoing. [9][10][11][12][13] Nepal started its vaccination drive with Covishield, a replication-deficient Chimpanzee Adenovirusvectored vaccine (Chad-Ox1-nCOV-19) followed by the Sinopharm -inactivated Vero cell vaccine, 14 both vaccines are almost equally covered in Nepal by till August 3, 2021. About 0.47 million people were vaccinated with Covishield and almost 0.7 million people with the Vero cell vaccine till the end of March 2022.…”
Section: Introductionmentioning
confidence: 99%
“…However, studies regarding the efficacy of Vero Cell vaccines are still ongoing. [9][10][11][12][13] Nepal started its vaccination drive with Covishield, a replication-deficient Chimpanzee Adenovirusvectored vaccine (Chad-Ox1-nCOV-19) followed by the Sinopharm -inactivated Vero cell vaccine, 14 both vaccines are almost equally covered in Nepal by till August 3, 2021. About 0.47 million people were vaccinated with Covishield and almost 0.7 million people with the Vero cell vaccine till the end of March 2022.…”
Section: Introductionmentioning
confidence: 99%